The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ ...

A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled “Imipridones ONC201/ONC206 + RT/TMZ ...

In our “Why I'm Running” series, Boston Marathon runners share what's inspiring them to make the 26.2-mile trek from ...

For glioblastoma, several strategies have been developed to enhance the immune response against cancers: Monoclonal ...

An Instagram reel claims that Nicotine cures glioblastoma tumors in less than 72 hours. The claim by the user is ...

Despite decades of research to develop effective treatments, the median survival for glioblastoma—the most common malignant ...

Scientists from Tomsk Polytechnic University, in collaboration with their colleagues, have successfully determined the impact ...

The FDA has granted 501(k) clearance to ZEISS INTRABEAM 700, a robotic-assisted platform designed to enhance intraoperative ...